Intuitive Surgical, Inc. (ISRG) Total Return CAGR:-18.93%(TTM)
The total return cagr for Intuitive Surgical, Inc. (ISRG) is -18.93% over the latest trailing 12-month period. The comparable SPY value is +24.32%. Year-to-date total return is -24.68%. Total return includes price appreciation and reinvested dividends.
The total return cagr for Intuitive Surgical, Inc. (ISRG) stock is -18.93% over the past 12 months. The 3 year average growth rate is 10.90% and the 5 year cagr is 8.78%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Intuitive Surgical, Inc.'s investment performance.
ISRG Total Return CAGR Chart
Intuitive Surgical, Inc. (ISRG)
ISRG Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 27899.51 | 21015.27 | -6884.24 | -24.68% | -24.68% |
| 2025 | 25712.32 | 27899.51 | +2187.19 | +8.51% | +8.51% |
| 2024 | 16618.72 | 25712.32 | +9093.60 | +54.72% | +54.72% |
| 2023 | 13071.43 | 16618.72 | +3547.29 | +27.14% | +27.14% |
| 2022 | 17699.51 | 13071.43 | -4628.08 | -26.15% | -26.15% |
| 2021 | 13433.50 | 17699.51 | +4266.01 | +31.76% | +31.76% |
| 2020 | 9706.90 | 13433.50 | +3726.60 | +38.39% | +38.39% |
| 2019 | 7864.04 | 9706.90 | +1842.86 | +23.43% | +23.43% |
| 2018 | 5992.61 | 7864.04 | +1871.43 | +31.23% | +31.23% |
| 2017 | 3470.94 | 5992.61 | +2521.67 | +72.65% | +72.65% |
| 2016 | 2989.16 | 3470.94 | +481.77 | +16.12% | +16.12% |
| 2015 | 2895.07 | 2989.16 | +94.09 | +3.25% | +3.25% |
| 2014 | 2102.46 | 2895.07 | +792.61 | +37.70% | +37.70% |
| 2013 | 2684.24 | 2102.46 | -581.77 | -21.67% | -21.67% |
| 2012 | 2534.48 | 2684.24 | +149.75 | +5.91% | +5.91% |
| 2011 | 1410.84 | 2534.48 | +1123.65 | +79.64% | +79.64% |
| 2010 | 1660.59 | 1410.84 | -249.75 | -15.04% | -15.04% |
| 2009 | 695.07 | 1660.59 | +965.52 | +138.91% | +138.91% |
| 2008 | 1767.98 | 695.07 | -1072.91 | -60.69% | -60.69% |
| 2007 | 525.12 | 1767.98 | +1242.86 | +236.68% | +236.68% |
| 2006 | 641.87 | 525.12 | -116.75 | -18.19% | -18.19% |
| 2005 | 219.21 | 641.87 | +422.66 | +192.81% | +192.81% |
| 2004 | 93.60 | 219.21 | +125.62 | +134.21% | +134.21% |
| 2003 | 67.49 | 93.60 | +26.11 | +38.69% | +38.69% |
| 2002 | 109.85 | 67.49 | -42.36 | -38.57% | -38.57% |
| 2001 | 93.10 | 109.85 | +16.75 | +17.99% | +17.99% |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa